FDA
approval
· 2022-11-16
FDA Approved: RUFINAMIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
Summary
The FDA approved Lupin Pharmaceuticals' supplemental application for Rufinamide (generic), expanding its regulatory status for the treatment of Lennox-Gastaut s…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RUFINAMIDE (RUFINAMIDE)